Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Wael AlMahmeed MD"'
Autor:
Rosaria Vincenza Giglio BD, PhD, Emir M. Muzurović MD, PhD, Angelo Maria Patti MD, PhD, Peter P. Toth MD, PhD, Manyoo A. Agarwal MD, Wael Almahmeed MD, Aleksandra Klisic MD, PhD, Marcello Ciaccio MD, PhD, Manfredi Rizzo MD, PhD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 28 (2023)
Background: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are low-density lipoprotein cholesterol (LDL-C)-lowering drugs that play a critical role in lipoprotein clearance and metabolism. PCSK9i are used in patients with familial
Externí odkaz:
https://doaj.org/article/faa1eeb0bb4341d0aad3475c053e45d6
Autor:
Wasim S. El Nekidy PharmD, Khalid Almuti MD, Hazem ElRefaei PharmD, Bassam Atallah PharmD, Lana M. Mohammad RPh, Wael AlMahmeed MD, Mohamed Badr MD, Khaled Abdallah MD, Fadi Hamed MD, Jihad Mallat MD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 27 (2022)
Background: Several reports linked the use of repurposed drugs such as hydroxychloroquine (HCQ), azithromycin, lopinavir/ritonavir, and favipiravir with QT interval prolongation in patients with SARS-CoV2 infection. Little is known about the risk fac
Externí odkaz:
https://doaj.org/article/4fac1f694f3d4ce7882706c10f8b41e4